Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

19.85
+1.357.30%
Post-market: 19.990.1400+0.71%19:50 EDT
Volume:1.89M
Turnover:37.06M
Market Cap:1.92B
PE:-3.40
High:19.94
Open:18.75
Low:18.70
Close:18.50
52wk High:42.37
52wk Low:18.29
Shares:96.48M
Float Shares:92.79M
Volume Ratio:0.67
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8316
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-22.03%
PB:-23.94
PE(LYR):-3.40

Loading ...

May 05, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 23, 2023

Major Issues Report

8-K - Current report
Mar 14, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 16, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2023

Major Issues Report

8-K - Current report
Dec 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2022

Major Issues Report

8-K - Current report
Oct 28, 2022

Major Issues Report

8-K - Current report
Sep 15, 2022

Major Issues Report

8-K - Current report
Jul 29, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]